Latest close: back above its 200-day averageSep 8, 2026what changed →
The financials
STAAR Surgical Company by the numbers
STAAR Surgical Company (STAA) reported revenue of $94M in Q1 2026 (quarter ended Apr 3, 2026), up 120% from the same quarter a year earlier. That came with a gross margin of 74% and net income of $5.2M (5.6% of revenue). For the full year FY2025, revenue was $239M (−24% year on year) and net income −$80M. Its largest region in Jun 2026 was Other Countries at $20M, 44% of the disclosed total, ahead of Japan at 25%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $94M | $43M | +120% |
| Gross profit | $69M | $28M | +146% |
| Operating income | $8.0M | −$57M | to a profit |
| Net income | $5.2M | −$54M | to a profit |
| Diluted EPS | $0.10 | −$1.10 | to a profit |
| Geographic | Revenue | Share |
|---|---|---|
| Other Countries | $20M | 44% |
| Japan | $11M | 25% |
| China | $9.5M | 21% |
| South Korea | $4.3M | 9.6% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $44.7M (-14%)
China grew +242% year on yearSouth Korea +0.09% year on year
Segment Latestquarter on quarteryear on year
- Other Countries$19.7M$19.7MQoQ +2.8%year on year +8.4%+2.8%+8.4%
- Japan$11.1M$11.1MQoQ -9.2%year on year +2.1%-9.2%+2.1%
- China$9.5M$9.5MQoQ -25%year on year +242%-25%+242%
- South Korea$4.3M$4.3MQoQ -46%year on year +0.09%-46%+0.09%
Medical Instruments & Supplies
Ranks #11 of 19 by Smart Score